Publikationen

Alzheimer’s & Dementia, 2022

Alzheimer’s & Dementia, 2022

Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

Annals of Clinical & Translational Neurology, 2021

Annals of Clinical & Translational Neurology, 2021

TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis

Alzheimer’s Research & Therapy, 2020

Alzheimer’s Research & Therapy, 2020

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline